I bought 5000 shares BII 2 years ago, just before
the rise and sharp drop caused by BSX and JNJ
discussions with BII. I am happy to see that Abbott is now
pushing the shares of this company with excellent and
high potential products up. And don't underestimate
the other productlines (Eyecare!!!).I believe it's
time to leave BSX messageboard talking about BII and
go to Abbotts'.
BSX is not worth the good news on
If you check out riceen.com, you will see why.
Hundreds of thousands visitors and thousands of followers
that buy on her command have to influence the price as
well as volume. Did you see what she did with GERN &
ZIXI this week? She runs 90% right on her selections.
The best thing that could happen to us was to get
Riceen to hype BSX. She will take it to her target in
less than a month. She was written up in Kiplinger's a
few months ago. She was called a Guru.
I didn't state EP was posting a profit. I said
EPT needs to be profitable. As for EPT
Target, that isn't so. Only the IVUS
group is moving.
EPT will remain intact at its current San Jose
Where did you hear that the EPT division was
posting a profit? Not that I know of - most of the
employees were relocated to the Target division just this
past week. Maybe this is an indication that cost
cutting IS FINALLY happening in San Jose!
hope the stock rises soon!
BSX successfully fulfilled their recall task
continue its highly-profitable production lines, and
aggressively work with FDA for some new products approval for
market. Both BSX management and
its employees are confidence in the coming
BSX is going up! BSX will move up to all time higher
before the next quater report!
As I mentioned three
months ago, anything below 22 is great buying
opportunity, we will see 30 soon.
Buy and hold, we will
have a very merry Christmas, period.
In responce to your question to the GUV, allow my
2 cents worth. IMO,,,
JNJ? - Bad Blood,
BSX? - Restricted by medinol
GDT? - Not Invented
MDT? - Just Bought AVE
that Bii was in discussion with Bard, then AVE so I am
a little surprised that MDT did not get involved
with them, IMO they were stretched a little thin with
the AVE pruchase.
I can also add that this
company was initially run by Alistair Taylor and for
whatever reason, he was not viewed very highly by the
other big whigs of the above companies. I have worked
with all of the above (including BII) on various
devices and got very negative vibes about how Bii was run
when they initlaly started (96). Alistair was
postioning Bii to have a full product line and to "dominate
the market" because of PC coating. He pissed off J&J
because they thought they were negotiating for
exclusivity and Alistair kind of stabed them in the back when
it became apparent that he would not give this up.
Unforntunately, the resource required and time required to get
products to market were grossly underestimated and as a
result, Bii almost went belly up prior to ever having
anything to sell. At one time, Bii had a sales force of 8
to 10 in the US with NOTHING to sell. When Bii
bought Atlantis, they fired the US sales force and
really looked foolish as a result. Shortly after that,
Alistair resigned (or was forced out)and I believe
virtually all management he hired has been
Consequnetly, within the inner circles of IC there are a lot of
negatives associated with Bii and their ability to
My question about Abbott is, will this be a case of
the blind leading the blind, does Abbott have the
resources and do they realize the nut they will have to
crack to get into this market.
If Bii continues
to show good results and if they get Drug Delivery
first it will help. The most important issue is for Bii
to produce volumes of product, very high quality,
with no boo-boo's.
I am happy with the recent
increase in stock price (3.5x) and I sincerely believe
that PC coating will have an impact on the US market.
I would have been more comfortable if their
distributiion partner was not a newcomer.
I concur with BSX badly needing a win in the AFib
market place however, they have not bet the ranch
through the application of existing catheter technology
as a viable solutiuon for AF. EPT does have a
superior generator and an array of catheter technology
products that are being used as a foundation for
developing an effective AF solution.
As for Mr.
Tobin needing EPT to be profitable,that's a given. All
BSX divisions need to post profits to ensure steady
growth is achieved as a corporation. Margins can be
improved by implementing operational efficiencies at all
levels of the corporation.